Documents for Download

Registry for long-term follow-up of CML patients who discontinued Imatinib after Complete Cytogenetic Response

for the registry on patients who discontinued imatinib after CCR
(Baseline) time of diagnosis
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Restart of Imatinib) (to be filled out at time of 1st restart of Imatinib and every 3 months thereafter)
(Therapeutic responses before the 1st disc. of I.) to be filled out every 3 months after diagnosis, but only as long as Imatinib was administered, otherwise refer to the 2nd Form